๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Structural modeling of the complex between an acetylcholine receptor-mimicking antibody and its snake toxin antigen

โœ Scribed by Catherine Tenette-Souaille; Jeremy C. Smith


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
811 KB
Volume
30
Category
Article
ISSN
0887-3585

No coin nor oath required. For personal study only.

โœฆ Synopsis


The antibody Mโฃ2-3 neutralizes the functional, acetylcholine receptor binding activity of its antigen, neurotoxin โฃ, and exhibits several other properties in common with the receptor itself. We present here the results of calculations examining the threedimensional structure of the toxin โฃ:Mโฃ2-3 complex. The antigen structure, determined by nuclear magnetic resonance spectroscopy, 1 was docked to models of the variable fragment of the antibody combining site 2 by using a method based on surface complementarity and maximization of buried surface area 3,4 while taking into account the possibility of conformational change on complexation. Extensive experimental information on the location of the functional epitope was incorporated into the analysis and used to screen candidate geometries of the complex resulting from the modeling. Eight plausible structures that are in accord with the experimental data were derived. Common structural features of the models are discussed, and residues of the antibody-combining site that are expected to play important roles in complexation are identified. In particular, three epitope residues that, according to mutagenesis experiments, make particularly strong contributions to the binding, interact excentrically and do not make contact with the central loops of the combining site, L3 and H3.


๐Ÿ“œ SIMILAR VOLUMES


The third-dimensional structure of the c
โœ Jens Kleinjung; Marie-Christine Petit; Piotr Orlewski; Avgi Mamalaki; Socrates J ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 351 KB ๐Ÿ‘ 2 views

## Binding of autoantibodies to the acetylcholine receptor (AChR) plays a major role in the autoimmune disease Myasthenia gravis (MG). In this paper, we propose a structure model of a putative immunocomplex that gives rise to the reduction of functional AChR molecules during the course of MG. The mo